Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Greater Cannabis Company (GCAN) EBT (2017 - 2026)

Greater Cannabis Company has reported EBT over the past 6 years, most recently at -$47401.0 for Q4 2022.

  • For Q4 2022, EBT rose 75.86% year-over-year to -$47401.0; the TTM value through Dec 2022 reached -$360268.0, up 40.18%, while the annual FY2025 figure was -$331612.0, 85.22% down from the prior year.
  • EBT for Q4 2022 was -$47401.0 at Greater Cannabis Company, up from -$102776.0 in the prior quarter.
  • Over five years, EBT peaked at $1.1 million in Q2 2020 and troughed at -$1.2 million in Q1 2020.
  • A 5-year average of -$219616.4 and a median of -$132389.5 in 2019 define the central range for EBT.
  • Biggest five-year swings in EBT: crashed 4578.56% in 2019 and later surged 483.09% in 2020.
  • Year by year, EBT stood at $24473.0 in 2018, then crashed by 4578.56% to -$1.1 million in 2019, then skyrocketed by 65.08% to -$382790.0 in 2020, then surged by 48.71% to -$196331.0 in 2021, then surged by 75.86% to -$47401.0 in 2022.
  • Business Quant data shows EBT for GCAN at -$47401.0 in Q4 2022, -$102776.0 in Q3 2022, and -$62405.0 in Q2 2022.